RESPIRATORY DISEASE TESTS

COVID-19 IgG ELISA

COVID-19 IgG ELISA

Request Info

The 2019-Novel Coronavirus is a new type of coronavirus belonging to the β genus. COVID-19 is an acute respiratory infection disease. Infected sick persons are the main source of transmission. But asymptomatic infected persons can also be sources of transmission. According to current epidemiological studies, the incubation period is between 1 and 14 days, but generally varies between 3 and 7 days.

General symptoms include pyrexia, fatigue, and dry cough. In a few cases, postnasal drip, nasal discharge, sore throat, myalgia, and diarrhea have been observed. The virus seems to be transmitted mainly through respiratory droplets that people sneeze, cough or breathe.

The COVID-19 IgG ELISA Kit is a qualitative in vitro enzyme immunoassay for the detection of IgG antibodies directed against SARS CoV-2 nucleocapsid antigen in human serum and plasma. COVID-19 IgG ELISA is an indirect ELISA.

  • The test can be performed with standard ELISA equipment or using an automated open-type ELISA analyzer.
  • It is intended for in vitro use by a laboratory specialist with its practical apply procedure.
  • It is used to detect antibodies with IgG isotypes in human serum and plasma.
  • Analyzes were performed by evaluating clinical samples using the RT-PCR reference method.

Covid-19 Ig ELISA

  • 71,93%
  • 99,2%
Product Type Sample Type Kit Size Additional Materials

Covid-19 Ig ELISA

ELISA Serum, Plasma 96 Seal